VERACYTE, INC. Share-based Payment Arrangement, Expense
VERACYTE, INC. (VCYT) reported Share-based Payment Arrangement, Expense of $43.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-02-26
- VERACYTE, INC. share-based payment arrangement, expense for fiscal 2025 was $43.60M, a 20.28% increase from fiscal 2024.
- VERACYTE, INC. share-based payment arrangement, expense for fiscal 2024 was $36.25M, a 9.38% increase from fiscal 2023.
- VERACYTE, INC. share-based payment arrangement, expense for fiscal 2023 was $33.14M, a 23.97% increase from fiscal 2022.
- VERACYTE, INC. share-based payment arrangement, expense for fiscal 2022 was $26.73M, a 18.72% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 12 month |
|---|---|
| 2025-12-31 | $43.60M 10-K · filed 2026-02-26 |
| 2024-12-31 | $36.25M 10-K · filed 2026-02-26 |
| 2023-12-31 | $33.14M 10-K · filed 2026-02-26 |
| 2022-12-31 | $26.73M 10-K · filed 2025-02-28 |
| 2021-12-31 | $22.52M 10-K · filed 2024-02-29 |
| 2020-12-31 | $12.99M 10-K · filed 2023-03-01 |
| 2019-12-31 | $9.81M 10-K · filed 2022-02-28 |
| 2018-12-31 | $5.96M 10-K · filed 2021-02-22 |
| 2017-12-31 | $6.62M 10-K · filed 2020-02-25 |
| 2016-12-31 | $6.38M 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |